The Principles of Cancer Biotherapy

The Principles of Cancer Biotherapy

Edited by 

List price: US$99.00

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

At the time of the first edition of this text, it represented a comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. It is now generally agreed that biopharmaceuticals are producing major opportunities for new cancer therapies. Cancer biotherapy has truly matured into the fourth modality of cancer treatment. This 3rd edition results from the tremendous progress that has been made in recent years using biologicals in cancer treatment. The book summarizes an evolving science and a rapidly changing medical practice. As we near the millennium, it now becomes possible to envision a much more diversified system of cancer research and treatment that should afford greater opportunities for patients. Some forms of cancer biotherapy use the strategy of tumour stabilization and control through continued biological therapy, akin to the use of insulin in the treatment of diabetes. This textbook illustrates new methods of thinking and new strategies for control of cancer.
It is always difficult to move from past dogma to future opportunity, but this text illustrates why it is so important to the patients, for researchers and clinicians to explore and apply these new opportunities in cancer biotherapy.
show more

Product details

  • Paperback | 892 pages
  • 209.55 x 230 x 31.75mm | 1,270.06g
  • Dordrecht, Netherlands, United States
  • English
  • Revised
  • 3rd Revised edition
  • index
  • 0792335074
  • 9780792335078

Table of contents

Cancer biotherapy - general principles, R.K. Oldham; the pathogenesis of cancer metastasis - relevance to biotherapy, R. Radinsky, et al; developmental therapeutics and the design of clinical trials; R.K. Oldham; recombinant organisms as sources of cancer biotherapeutics, K. Mehta, B.B. Aggarwal; current concepts in immunology, R.K. Oldham; cancer-associated immune suppression - therapeutic alterations with chemical and biological agents, R.K. Oldham; nonspecific immunomodulators in oncology and haematology, G. Mathe, S. Orbach; cancer vaccines - tumour epitopes and gene therapy, G.C. Fareed, L.E. Spitler; chemical inducers of lymphokines, R.V. Salley, R.K. Oldham; lymphokines and cytokines, W. Lewko, et al; interferon therapy in cancer, R.V. Smalley, et al; antibody therapy, R.O. Dillman; immunotoxins, L.E. Spitler; drug immunoconjugates, R.K. Oldham, K.A. Foon; radiolabeled monoclonal antibodies for localization and treatment of metastatic cancer, H.B. Breitz, et al; stem cell/bone marrow transplantation as biotherapy, R.K. Oldham; cancer adoptive cellular immunotherapy, J.R. Yannelli; growth and maturation factors in cancer, R.K. Oldham; G-CSF, G. Morstyn, et al; GM-CSF, A. Jakubowski; clinical approaches to cancer gene therapy, K.A. Whartenby, et al; cancer biotherapy - 1990s disease-related activity, R.K. Oldham, et al; speculations for the 1990s, R.K. Oldham.
show more